Status:
COMPLETED
De-prescribing Program to Evaluate Falls in Older Adults
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Opioid-Related Disorders
Benzodiazepine-Related Disorders
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Purpose: The proposed study will implement and evaluate the effect of an opioid and benzodiazepine (BZD) de-prescribing intervention on falls risk in older adults. Participants: Outpatient clinics wi...
Detailed Description
Falls among older adults is costly and dangerous. Observational studies show consistent associations between falls and certain medications. It is widely accepted that falls-related morbidity and morta...
Eligibility Criteria
Inclusion
- UNC HealthCare clinic providing primary care services
- age at least 65 years old
- taking at least one chronic opioid or one chronic benzodiazepine medication
Exclusion
- Clinics that do not provided primary care services
- Patients who exhibit signs of cognitive impairment or speech/hearing deficits that make obtaining informed consent and completing data collection activities difficult
- Patients undergoing active cancer treatment, receiving hospice care, or living in a skilled nursing facility
- Non-English speaking patients will be excluded from participating in the patient focus group.
- Participants who do not wish to be audio-recorded during focus group
Key Trial Info
Start Date :
February 26 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04272671
Start Date
February 26 2020
End Date
October 1 2021
Last Update
January 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599